China Film Co.,Ltd. (600977.SS) Bundle
Investors looking for a data-driven take on China Film Co., Ltd. (600977.SS) will want to dive into how a Q3 2025 revenue surge to CNY 1.21 billion - up 35.71% year-over-year - fits into a TTM revenue of CNY 4.49 billion after a 2024 annual decline from CNY 5.34 billion to CNY 4.57 billion; juxtapose that top-line momentum with a Q3 2025 net income rebound to CNY 176.73 million and a modest TTM net profit margin of 3.07% while EPS hovers near break-even and the trailing P/E sits at an elevated 127.38, and you get a company with CNY 10.87 billion in cash and short-term investments, total liabilities of CNY 7.45 billion, equity of CNY 11.49 billion, a conservative debt-to-equity of 0.20, strong liquidity ratios (current 2.43, quick 2.03) but negative operating cash flow and worrying interest coverage of -3.67; market valuation metrics - market cap roughly CNY 30.69 billion with a share price of CNY 16.77 (Dec 18, 2025) and a forward P/E of 32.47 alongside an EV/EBITDA of -62.79 - sit against a low dividend yield of 0.72% and analyst expectations of revenue rising to about $1.2 billion by 2025, setting up a compelling risk-reward picture that this article will unpack in full detail for readers weighing regulatory, operational and growth catalysts.
China Film Co.,Ltd. (600977.SS) - Revenue Analysis
China Film Co.,Ltd. reported mixed revenue trends across recent periods, with a strong Q3 2025 rebound but a prior annual contraction in 2024. Key figures and ratios frame the company's sales performance, productivity per employee, and market valuation.- Q3 2025 revenue: CNY 1.21 billion, up 35.71% year-over-year (vs Q3 2024).
- Trailing twelve months (TTM) revenue: CNY 4.49 billion, +8.33% YoY.
- Full-year 2024 revenue: CNY 4.57 billion, a 14.28% decline from CNY 5.34 billion in 2023.
- Revenue per employee: ~CNY 1.51 million (total employees: 2,977).
- Price-to-Sales (P/S) ratio: 6.84.
- Market capitalization: CNY 30.69 billion; share price: CNY 16.77 (as of 18 Dec 2025).
| Metric | Value | YoY Change / Note |
|---|---|---|
| Q3 2025 Revenue | CNY 1.21 billion | +35.71% vs Q3 2024 |
| TTM Revenue | CNY 4.49 billion | +8.33% YoY |
| 2024 Annual Revenue | CNY 4.57 billion | -14.28% vs 2023 (CNY 5.34 billion) |
| Revenue per Employee | CNY 1.51 million | Employees: 2,977 |
| Price-to-Sales (P/S) | 6.84 | Market valuation relative to sales |
| Market Capitalization | CNY 30.69 billion | Share price: CNY 16.77 (18 Dec 2025) |
- Implications: The Q3 2025 surge suggests renewed box-office/content momentum or core-business recovery, while the 2024 annual decline highlights episodic volatility in revenue drivers.
- Valuation context: A P/S of 6.84 implies market expectations for growth or margin expansion relative to peers; compare with sector averages before drawing valuation conclusions.
- Productivity: Revenue per employee (~CNY 1.51M) provides a productivity benchmark for evaluating operational efficiency and potential scaling effects if revenues normalize or grow.
China Film Co.,Ltd. (600977.SS) - Profitability Metrics
China Film Co.,Ltd. reported a material operating improvement in Q3 2025 with net income of CNY 176.73 million, reversing a net loss in Q3 2024. The trailing-twelve-month (TTM) picture shows modest profitability and limited returns to shareholders.- Q3 2025 net income: CNY 176.73 million (turnaround vs Q3 2024 loss)
- TTM net profit margin: 3.07%
- TTM EBITDA: CNY 66.95 million
- ROE: 0.51%
- TTM EPS: CNY -0.00 (near break-even)
- Dividend yield: 0.72% (annualized payout CNY 0.12 per share)
| Metric | Value | Period |
|---|---|---|
| Net Income | CNY 176.73 million | Q3 2025 |
| Net Profit Margin | 3.07% | TTM |
| EBITDA | CNY 66.95 million | TTM |
| Return on Equity (ROE) | 0.51% | Latest reported |
| Earnings Per Share (EPS) | CNY -0.00 | TTM |
| Dividend Yield / Annualized Payout | 0.72% / CNY 0.12 per share | Annualized |
China Film Co.,Ltd. (600977.SS) - Debt vs. Equity Structure
As of September 2025, China Film Co.,Ltd. shows a conservative capital structure with strong short-term liquidity but strained ability to cover interest from operating income.- Cash & short-term investments: CNY 10.87 billion
- Total liabilities: CNY 7.45 billion
- Total equity: CNY 11.49 billion
- Debt-to-equity ratio: 0.20
- Current ratio: 2.43
- Quick ratio: 2.03
- Interest coverage ratio: -3.67
| Metric | Value |
|---|---|
| Cash & short-term investments | CNY 10.87 billion |
| Total liabilities | CNY 7.45 billion |
| Total equity | CNY 11.49 billion |
| Debt-to-equity ratio | 0.20 |
| Current ratio | 2.43 |
| Quick ratio | 2.03 |
| Interest coverage ratio (EBIT/Interest) | -3.67 |
- Low leverage (D/E 0.20) reduces solvency risk and leaves room for disciplined borrowing if growth or M&A opportunities arise.
- High cash relative to liabilities supports operational flexibility, dividend capacity, or buyback potential, subject to governance and strategy.
- Current and quick ratios well above 1 indicate robust short-term liquidity without dependence on inventory conversion.
- Negative interest coverage (-3.67) signals operating losses or interest expense that outstrip EBIT; this materially raises refinancing and profitability risk despite ample cash.
- Persistent negative coverage would warrant monitoring of operating performance, cost structure, and interest-bearing debt maturity profile.
China Film Co.,Ltd. (600977.SS) - Liquidity and Solvency
China Film Co.,Ltd. shows a mixed liquidity and solvency profile: a strong headline cash-to-debt cushion contrasts with weak operating cash generation and sharply declining cash flow metrics.- Cash-to-debt ratio: ~4.56 - indicates a substantial cash buffer relative to total debt.
- Operating cash flow: negative - operations are not currently producing net cash inflows.
- Net change in cash (Q3 2025): CNY 22.03 million - down 97.99% YoY, signaling a near-elimination of net cash build during the period.
- Free cash flow (latest): CNY 37.79 million - declined 93.16% YoY, reflecting sharply reduced cash available after capital expenditures.
- Effective tax rate: 19.15% - represents the company's current tax burden on pre-tax earnings.
- Return on assets (ROA): 3.25% - modest asset efficiency in generating net income.
| Metric | Value | YoY Change |
|---|---|---|
| Cash-to-Debt Ratio | 4.56 | - |
| Operating Cash Flow | Negative (latest period) | - |
| Net Change in Cash (Q3 2025) | CNY 22.03 million | -97.99% |
| Free Cash Flow | CNY 37.79 million | -93.16% |
| Effective Tax Rate | 19.15% | - |
| Return on Assets (ROA) | 3.25% | - |
China Film Co.,Ltd. (600977.SS) Valuation Analysis
China Film Co.,Ltd. (600977.SS) presents a valuation profile that signals elevated market expectations despite underlying profitability challenges. Key headline metrics as of December 19, 2025 show a market capitalization of CNY 30.49 billion and a share price of CNY 16.33, while several valuation multiples reflect both growth optimism and near-term earnings pressure.- Trailing P/E: 127.38 - implies the market is pricing in significant future earnings expansion relative to the last 12 months of reported earnings.
- Forward P/E: 32.47 - indicates analysts expect earnings to recover/expand materially versus trailing results.
- P/B: 1.90 - the stock trades at roughly 1.9x book value, suggesting modest premium to net asset backing.
- EV/Revenue: 2.47 - the enterprise value implies investors are paying CNY 2.47 for each CNY 1 of revenue.
- EV/EBITDA: -62.79 - a negative multiple reflecting reported negative EBITDA, complicating standard profitability valuation.
| Metric | Value | Interpretation |
|---|---|---|
| Market Capitalization | CNY 30.49 billion | Size of equity market value as of 2025-12-19 |
| Share Price | CNY 16.33 | Closing price on 2025-12-19 |
| Trailing P/E | 127.38 | Very high relative to historical norms - signals strong growth expectations or depressed trailing earnings. |
| Forward P/E | 32.47 | Expectations of earnings improvement; still elevated versus many peers. |
| Price-to-Book (P/B) | 1.90 | Market values company at nearly twice its book equity. |
| EV/Revenue | 2.47 | Moderate revenue multiple for a media/entertainment company. |
| EV/EBITDA | -62.79 | Negative due to negative EBITDA - traditional EV/EBITDA comparisons are unreliable. |
- High trailing P/E (127.38) combined with a much lower forward P/E (32.47) suggests recent earnings were weak but that the market (and analysts) expect material recovery or one-time distortions to normalize.
- Negative EV/EBITDA (-62.79) flags current operational cash-profitability issues; investors should assess the drivers (e.g., content costs, box-office variability, non-recurring charges).
- P/B of 1.90 implies limited balance-sheet downside protection but not an extreme premium; consider asset quality and intangible valuation (IP rights, distribution networks).
China Film Co.,Ltd. (600977.SS) Risk Factors
China Film Co.,Ltd. operates in a high-regulation, capital-intensive entertainment industry where several quantifiable risks stand out and materially affect investor returns and valuation assumptions.- Regulatory and content risk: subject to strict government oversight and content censorship that can delay releases, limit box-office potential, or require costly edits.
- Thin profitability: reported revenue of CNY 4,570,000,000 with a modest net income margin of ~3%, implying net income of approximately CNY 137,100,000 - a narrow cushion against downside shocks.
- Shareholder returns constrained: diluted EPS of CNY -0.05 and a minimal dividend yield (near 0%) indicate limited capacity to deliver cash returns to equity holders.
- Cash-generation challenges: negative operating cash flow indicates difficulty converting accounting profits into cash available for reinvestment, debt service, or dividends.
- Interest burden: an interest coverage ratio of -3.67 highlights the company's operating income is insufficient to cover interest expenses, raising refinancing and solvency concerns.
- Conservative leverage but limited flexibility: debt-to-equity ratio of 0.20 demonstrates low financial leverage; while lowering default risk, it may constrain capital deployment and growth if management is overly risk-averse.
| Metric | Value |
|---|---|
| Revenue (FY) | CNY 4,570,000,000 |
| Net Income Margin | ~3% |
| Estimated Net Income | CNY 137,100,000 |
| Diluted EPS | CNY -0.05 |
| Dividend Yield | Minimal (near 0%) |
| Operating Cash Flow | Negative (net outflow) |
| Interest Coverage Ratio | -3.67 |
| Debt-to-Equity Ratio | 0.20 |
- Implication for investors: low margins and negative operating cash flow reduce resilience to box-office volatility and regulatory interruptions; negative EPS combined with poor interest coverage increases downside risk to equity holders.
- Monitoring priorities: changes in regulatory guidance, quarterly cash-flow trends, interest expense trajectory, and any shift in dividend policy or capital-structure decisions.
China Film Co.,Ltd. (600977.SS) - Growth Opportunities
China Film Co.,Ltd. (600977.SS) sits at the intersection of content creation, distribution, exhibition and ancillary monetization - a structure that supports multi-channel revenue growth. Analysts forecast the company's revenue to rise from $800 million in 2023 to about $1.2 billion by 2025, implying an annual growth rate near 15%. Key drivers and quantifiable levers behind that projection include streaming partnerships, import privileges, strengthened in-house production and diversified operations such as theater management and lottery ticket sales.- Streaming partnerships: Collaborations with Tencent Video and iQIYI are expected to expand digital distribution and monetize content rights, projected to add roughly $200 million in revenue by 2024.
- Import authorizations: As one of the few firms authorized to import foreign films, China Film captures a portion of international box office spillover and revenue-sharing arrangements from major overseas releases.
- In-house production pipeline: Investment in domestic blockbusters increases upside from high-margin IP ownership and downstream licensing (merchandise, OTT windows, international theatrical runs).
- Integrated value chain: Ownership/participation across production → distribution → exhibition allows China Film to capture margins at multiple points and optimize release windows.
- Diversification via exhibition and lotteries: Extensive theater management operations and lottery ticket sales provide recurring cash flows distinct from content seasonality.
| Revenue Segment | 2023 (Actual, $M) | 2024 (Est., $M) | 2025 (Forecast, $M) |
|---|---|---|---|
| Distribution & Licensing (including streaming deals) | 300 | 420 | 540 |
| Exhibition (box office, ticketing) | 200 | 230 | 270 |
| Production & IP commercialization | 150 | 180 | 240 |
| Import rights & foreign film participation | 100 | 120 | 140 |
| Theater management & lottery ticket sales | 50 | 70 | 110 |
| Total Revenue | 800 | 1,020 | 1,200 |
- Projected CAGR (2023-2025): ~15% - driven by content monetization uplift and the $200M incremental contribution from major streaming collaborations by 2024.
- Margin expansion potential: Higher-margin streaming licensing and IP commercialization can lift consolidated gross margins vs. pure exhibition revenues.
- International upside: Successful domestic titles exported overseas and participation in global tentpoles (via import rights) offer asymmetric upside in high-performing release years.
- Balance-sheet/cash flow benefits: Recurring receipts from theater operations and lottery channels reduce revenue volatility tied solely to box-office cycles.

China Film Co.,Ltd. (600977.SS) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.